{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:03:54Z","timestamp":1790503434480,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["SVV 260519\/2020"],"award-info":[{"award-number":["SVV 260519\/2020"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/16_013\/0001775"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_013\/0001775"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["LO1507"],"award-info":[{"award-number":["LO1507"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["LM2018133"],"award-info":[{"award-number":["LM2018133"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/06634-8"],"award-info":[{"award-number":["2019\/06634-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/23844-8"],"award-info":[{"award-number":["2016\/23844-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["20-13946Y"],"award-info":[{"award-number":["20-13946Y"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007426","name":"Russell Berrie Nanotechnology Institute, Technion-Israel Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["20-15077Y"],"award-info":[{"award-number":["20-15077Y"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jconrel.2021.03.013","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:29:24Z","timestamp":1615508964000},"page":"529-538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects"],"prefix":"10.1016","volume":"332","author":[{"given":"Lindomar J.C.","family":"Albuquerque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Sincari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kucka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Humajova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Pankrac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Paral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Heizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Janou\u0161kova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Davidovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeshayahu","family":"Talmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Pouckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"\u0160t\u011bp\u00e1nek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludek","family":"Sefc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando C.","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli\u00e9zer","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.03.013_bb0005","series-title":"Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018","author":"Latest Global Cancer Data","year":"2018"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0010","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3892\/or.2010.1100","article-title":"Camptothecin induces DNA strand breaks and is cytotoxic in stimulated normal lymphocytes","volume":"25","author":"Yamauchi","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamainternmed.2016.7761","article-title":"Quality of life, overall survival, and costs of cancer drugs approved based on surrogate endpoints","volume":"177","author":"Rupp","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40169-018-0185-6","article-title":"Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs","volume":"7","author":"Maeda","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0030","first-page":"11","article-title":"Paclitaxel in breast cancer","volume":"2","author":"Patt","year":"2006","journal-title":"Women\u2019s Heal."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0035","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO;2-P","article-title":"Early and delayed clinical cardiotoxicity of doxorubicin","volume":"55","author":"Buzdar","year":"1985","journal-title":"Cancer."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0040","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10549-015-3415-2","article-title":"Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study","volume":"151","author":"Gil-Gil","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0045","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1200\/JCO.2004.03.516","article-title":"Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the north central cancer treatment group N9831 intergroup adjuvant trial","volume":"22","author":"Perez","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0050","doi-asserted-by":"crossref","first-page":"H3111","DOI":"10.1152\/ajpheart.00328.2007","article-title":"Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27","volume":"293","author":"Turakhia","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0055","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/jjco\/hyn101","article-title":"Phase II clinical trial of pegylated liposomal doxorubicin (JNS002) in Japanese patients with m\u00fcllerian carcinoma (Epithelial ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma) having a therapeutic history of platinum-based chem","volume":"38","author":"Katsumata","year":"2008","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules23040907","article-title":"Liposomal drug delivery systems and anticancer drugs","volume":"23","author":"Olusanya","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0065","author":"Doxorubicin Market By Application"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0070","doi-asserted-by":"crossref","first-page":"E818","DOI":"10.1503\/cmaj.111309","article-title":"Hand-foot syndrome related to chemotherapy","volume":"184","author":"Qiao","year":"2012","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0075","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000479878","article-title":"Drug-induced pseudoallergy: a review of the causes and mechanisms","volume":"101","author":"Zhang","year":"2018","journal-title":"Pharmacology"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000451069","article-title":"Complement activation-related pseudo-allergy: a fresh look at hypersensitivity reactions to intravenous Iron","volume":"45","author":"Macdougall","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0085","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","article-title":"Anti-PEG antibodies in the clinic: current issues and beyond PEGylation","volume":"244","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0090","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3390\/molecules23071700","article-title":"Understanding the role of anti-PEG antibodies in the complement activation by doxil in vitro","volume":"23","author":"Neun","year":"2018","journal-title":"Molecules."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2019.02.001","article-title":"Anti-PEG antibodies inhibit the anticoagulant activity of PEGylated aptamers","volume":"26","author":"Moreno","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0105","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomedicine Nanobiotechnology."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-3659(02)00462-5","article-title":"Accelerated clearance of pegylated liposomes in rats after repeated injections","volume":"88","author":"Kiwada","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.023","article-title":"The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes","volume":"213","author":"Kierstead","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0120","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.addr.2009.12.002","article-title":"HPMA copolymers for modulating cellular signaling and overcoming multidrug resistance","volume":"62","author":"Minko","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0125","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/1535-7163.MCT-15-0713-T","article-title":"Paclitaxel-loaded polymersomes for enhanced intraperitoneal chemotherapy","volume":"15","author":"Simon-Gracia","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0130","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.2217\/nnm.15.110","article-title":"Polymersomes and their applications in cancer delivery and therapy","volume":"10","author":"Guan","year":"2015","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/wnan.1183","article-title":"Smart polymersomes for therapy and diagnosis: fast progress toward multifunctional biomimetic nanomedicines","volume":"4","author":"De Oliveira","year":"2012","journal-title":"Wiley Interdiscip. Rev. Nanomedicine Nanobiotechnology."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.nano.2011.05.008","article-title":"The in vivo behavior and antitumor activity of doxorubicin-loaded poly(\u03b3-benzyl l-glutamate)-block-hyaluronan polymersomes in Ehrlich ascites tumor-bearing BalB\/c mice","volume":"8","author":"Upadhyay","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0145","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc.2017.77","article-title":"Tumour acidosis: from the passenger to the driver\u2019s seat","volume":"17","author":"Corbet","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3110","article-title":"Dysregulated pH: a perfect storm for cancer progression","volume":"11","author":"Webb","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0155","doi-asserted-by":"crossref","first-page":"9316","DOI":"10.1039\/c1sm05992k","article-title":"pH-triggered block copolymer micelles based on a pH-responsive PDPA (poly[2-(diisopropylamino)ethyl methacrylate]) inner core and a PEO (poly(ethylene oxide)) outer shell as a potential tool for the cancer therapy","volume":"7","author":"Giacomelli","year":"2011","journal-title":"Soft Matter"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jconrel.2012.11.009","article-title":"Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyesters","volume":"165","author":"J\u00e4ger","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0165","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/jbm.820211106","article-title":"Effect of molecular weight (Mw) ofN-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats","volume":"21","author":"Seymour","year":"1987","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0170","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1039\/c004036c","article-title":"Polymersome production on a microfluidic platform using pH sensitive block copolymers","volume":"10","author":"Brown","year":"2010","journal-title":"Lab Chip"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0175","article-title":"Microfluidic-assisted engineering of quasi-monodisperse pH-responsive polymersomes toward advanced platforms for the intracellular delivery of hydrophilic therapeutics","volume":"35","author":"Albuquerque","year":"2019","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0180","first-page":"1","article-title":"Controllable microfluidic production of drug-loaded PLGA nanoparticles using partially water-miscible mixed solvent microdroplets as a precursor","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0185","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1039\/C5PY00567A","article-title":"Nanoparticles of the poly([N-(2-hydroxypropyl)]methacrylamide)-b-poly[2-(diisopropylamino)ethyl methacrylate] diblock copolymer for pH-triggered release of paclitaxel","volume":"6","author":"J\u00e4ger","year":"2015","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0190","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0195","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.progpolymsci.2007.05.008","article-title":"Polymer-drug conjugation, recent achievements and general strategies","volume":"32","author":"Pasut","year":"2007","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0200","first-page":"191","article-title":"Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors","volume":"55","author":"Kissel","year":"2001","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0205","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0210","doi-asserted-by":"crossref","first-page":"9567","DOI":"10.1021\/acsnano.7b07214","article-title":"New insights into \u201cpermeability\u201d as in the enhanced permeability and retention effect of cancer nanotherapeutics","volume":"11","author":"Nel","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0215","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jconrel.2011.07.028","article-title":"Circulation kinetics and biodistribution of dual-labeled polymersomes with modulated surface charge in tumor-bearing mice: comparison with stealth liposomes","volume":"155","author":"Lee","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0220","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s11051-010-9886-5","article-title":"Polymersomes, smaller than you think: ferrocene as a TEM probe to determine core structure","volume":"12","author":"Johnston","year":"2010","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0225","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1166\/jbn.2016.2178","article-title":"Pharmacokinetics of polymersomes composed of poly(butadiene-ethylene oxide); healthy versus tumor-bearing mice","volume":"12","author":"Wang","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06445-z","article-title":"Influence of doxorubicin on model cell membrane properties: insights from in vitro and in silico studies","volume":"7","author":"Alves","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0005-2736(98)00175-8","article-title":"Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient","volume":"1415","author":"Li","year":"1998","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.11.021","article-title":"An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil\u00ae, Caelyx\u00ae, DOXOrubicin, and SinaDoxosome","volume":"221","author":"Wibroe","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0245","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1016\/j.biomaterials.2013.01.101","article-title":"Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles","volume":"34","author":"Cui","year":"2013","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0250","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/nl100996u","article-title":"Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy","volume":"10","author":"Yang","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0255","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1007\/s11095-012-0783-8","article-title":"In vivo evaluation of doxorubicin-loaded (PEG)3-PLA nanopolymersomes (PolyDoxSome) using DMBA-induced mammary carcinoma rat model and comparison with marketed LipoDoxTM","volume":"29","author":"Ayen","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0260","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.bjc.6690019","article-title":"Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein","volume":"79","author":"Van Asperen","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2021.03.013_bb0265","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biomaterials.2017.06.041","article-title":"Riboflavin-containing telodendrimer nanocarriers for efficient doxorubicin delivery: high loading capacity, increased stability, and improved anticancer efficacy","volume":"141","author":"Guo","year":"2017","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0270","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.biomaterials.2009.12.043","article-title":"The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(\u03b3-benzyl l-glutamate)-b-hyaluronan polymersomes","volume":"31","author":"Upadhyay","year":"2010","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0275","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2165\/00002018-200124120-00004","article-title":"A comparison of liposomal formulations of doxorubicin with drug administered in free form","volume":"24","author":"Waterhouse","year":"2001","journal-title":"Drug Saf."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0280","first-page":"2796","article-title":"Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes)","volume":"53","author":"Cowens","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2021.03.013_bb0285","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijpharm.2012.07.049","article-title":"Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs","volume":"436","author":"Suzuki","year":"2012","journal-title":"Int. J. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921001243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921001243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:40:06Z","timestamp":1777509606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921001243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":57,"alternative-id":["S0168365921001243"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.03.013","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}